Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Parallel-Filter Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan-HCTZ Combination as Compared to Losartan Monotherapy in Patients With Essential Hypertension

NCT00307060 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00307060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00307060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Parallel-Filter Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan-HCTZ Combination as Compared to Losartan Monotherapy in Patients With Essential Hypertension
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2004
Completion date
June 2, 2005
Enrollment
274 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mild to severe hypertension